M Buti Selected Research

M Buti Research Topics

Disease

21	Infections 08/2020 - 01/2001
20	Chronic Hepatitis C 02/2019 - 01/2000
16	Chronic Hepatitis B 01/2018 - 09/2000
9	Fibrosis (Cirrhosis) 02/2019 - 01/2000
6	Hepatitis B 11/2017 - 10/2000
6	Hepatitis 02/2006 - 09/2000
5	Hepatitis C 08/2020 - 01/2012
4	Hepatocellular Carcinoma (Hepatoma) 02/2019 - 06/2011
4	Hepatitis A (Hepatitis, Infectious) 01/2001 - 02/2000
3	Liver Diseases (Liver Disease) 05/2014 - 11/2007
2	Liver Cirrhosis (Hepatic Cirrhosis) 07/2012 - 10/2004
2	Coinfection 03/2010 - 08/2001
1	Liver Neoplasms (Liver Cancer) 05/2018
1	Disease Progression 07/2015
1	Hyperbilirubinemia 11/2014
1	Hepatitis D 11/2014
1	Thrombocytopenia (Thrombopenia) 11/2014
1	Persistent Infection 05/2014
1	HIV Infections (HIV Infection) 07/2012
1	Hemolysis 01/2012
1	Human Influenza (Influenza) 01/2012
1	Body Weight (Weight, Body) 03/2003
1	Chronic Hepatitis (Chronic Active Hepatitis) 11/2001
1	Viremia 08/2001
1	Anemia 04/2000

Drug/Important Bio-Agent (IBA)

14	InterferonsIBA 05/2018 - 01/2000
12	Ribavirin (Virazole)FDA LinkGeneric 11/2017 - 01/2000
9	Lamivudine (Epivir)FDA Link 04/2015 - 04/2001
8	Antiviral Agents (Antivirals)IBA 08/2020 - 11/2007
8	Hepatitis B e AntigensIBA 01/2018 - 06/2005
6	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2018 - 05/2002
6	RNA (Ribonucleic Acid)IBA 07/2012 - 04/2000
6	DNA (Deoxyribonucleic Acid)IBA 07/2010 - 04/2001
4	adefovirIBA 03/2010 - 11/2005
3	Tenofovir (Viread)FDA Link 01/2018 - 11/2016
3	SofosbuvirIBA 11/2017 - 01/2017
3	lipoarabinomannan (LAM)IBA 04/2015 - 09/2007
3	adefovir dipivoxil (Hepsera)FDA Link 07/2011 - 11/2005
2	Immunoglobulin G (IgG)IBA 07/2012 - 09/2000
2	Alanine Transaminase (SGPT)IBA 07/2012 - 01/2001
2	peginterferon alfa-2b (Pegintron)FDA Link 03/2004 - 03/2003
2	Interferon-alpha2bIBA 11/2001 - 04/2000
2	Hepatitis A AntibodiesIBA 01/2001 - 09/2000
2	VaccinesIBA 10/2000 - 02/2000
2	AntibodiesIBA 09/2000 - 03/2000
1	AntigensIBA 11/2017
1	velpatasvirIBA 11/2017
1	daclatasvirIBA 11/2017
1	sofosbuvir drug combination ledipasvirIBA 01/2017
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2017
1	SimeprevirIBA 01/2017
1	NucleotidesIBA 01/2017
1	peginterferon alfa-2a (Pegasys)FDA Link 11/2016
1	alisporivirIBA 07/2015
1	ButyrophilinsIBA 07/2015
1	Immunoglobulins (Immunoglobulin)IBA 04/2015
1	hepatitis B hyperimmune globulinIBA 04/2015
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 11/2014
1	AlbuminsIBA 11/2014
1	Indicators and Reagents (Reagents)IBA 05/2014
1	Anti-Idiotypic AntibodiesIBA 07/2012
1	Oseltamivir (Tamiflu)FDA Link 01/2012
1	Telbivudine FDA Link 03/2010
1	Emtricitabine (Emtriva)FDA Link 03/2010
1	NucleosidesIBA 11/2007
1	Transferrin (beta 2 Transferrin)IBA 10/2004
1	IronIBA 10/2004
1	Interferon-alpha (Interferon Alfa)IBA 09/2002
1	Transaminases (Aminotransferases)IBA 05/2002
1	Immunoglobulin M (IgM)IBA 01/2001
1	Combined VaccinesIBA 10/2000
1	A-factor (Streptomyces)IBA 10/2000
1	Hepatitis C AntibodiesIBA 03/2000

Therapy/Procedure

23	Therapeutics 11/2017 - 01/2000
4	Liver Transplantation 02/2019 - 11/2005
1	Salvage Therapy 09/2009
1	Duration of Therapy 10/2000